Genome-Wide CRISPR Screening Identifies JAK1 Deficiency as a Mechanism of T-Cell Resistance

por Han, Ping, Dai, Qiang, Fan, Lilv, Lin, Hao, Zhang, Xiaoqing, Li, Fanlin, Yang, Xuanming
Publicado 2019

Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity

por Qi, Xinyue, Li, Fanlin, Wu, Yi, Cheng, Chen, Han, Ping, Wang, Jieyi, Yang, Xuanming
Publicado 2019

4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2(nd) Generation Chimeric Antigen Receptor-Modified T Cells

por Dai, Qiang, Han, Ping, Qi, Xinyue, Li, Fanlin, Li, Min, Fan, Lilv, Zhang, Huihui, Zhang, Xiaoqing, Yang, Xuanming
Publicado 2020

Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis

por Wang, Haiyong, Han, Ping, Qi, Xinyue, Li, Fanlin, Li, Min, Fan, Lilv, Zhang, Huihui, Zhang, Xiaoqing, Yang, Xuanming
Publicado 2021

A CLDN18.2-Targeting Bispecific T Cell Co-Stimulatory Activator for Cancer Immunotherapy

por Liang, Jie, Zhang, Huihui, Huang, Yue, Fan, Lilv, Li, Fanlin, Li, Min, Yan, Yaping, Zhang, Junshi, Li, Zeyu, Yang, Xuanming
Publicado 2021

Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC

por Fan, Lilv, Xu, Guiliang, Cao, Jingjing, Li, Min, Zhang, Huihui, Li, Fanlin, Qi, Xinyue, Zhang, Xiaoqing, Li, Zeyu, Han, Ping, Yang, Xuanming
Publicado 2021

Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection

por Zhang, Xiaoqing, Han, Ping, Wang, Haiyong, Xu, Yanqin, Li, Fanlin, Li, Min, Fan, Lilv, Zhang, Huihui, Dai, Qiang, Lin, Hao, Qi, Xinyue, Liang, Jie, Wang, Xin, Yang, Xuanming
Publicado 2021

T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies

por Li, Fanlin, Zhang, Huihui, Wang, Wanting, Yang, Puyuan, Huang, Yue, Zhang, Junshi, Yan, Yaping, Wang, Yuan, Ding, Xizhong, Liang, Jie, Qi, Xinyue, Li, Min, Han, Ping, Zhang, Xiaoqing, Wang, Xin, Cao, Jiang, Fu, Yang-Xin, Yang, Xuanming
Publicado 2022

A spike-targeting bispecific T cell engager strategy provides dual layer protection against SARS-CoV-2 infection in vivo

por Li, Fanlin, Xu, Wei, Zhang, Xiaoqing, Wang, Wanting, Su, Shan, Han, Ping, Wang, Haiyong, Xu, Yanqin, Li, Min, Fan, Lilv, Zhang, Huihui, Dai, Qiang, Lin, Hao, Qi, Xinyue, Liang, Jie, Wang, Xin, Jiang, Shibo, Xie, Youhua, Lu, Lu, Yang, Xuanming
Publicado 2023